Proliferation and p53 expression in anal cancer precursor lesions

Anticancer Research

Volumn 23, Issue 3 C, 2003, Pages 2995-2999

  Mullerat, J ^a   Deroide, F ^a   Winslet, M C ^a   Perrett, C W ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

AIN; Cancer; Ki67; p53

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ANTIGEN EXPRESSION; ANUS CARCINOMA; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DYSPLASIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; DISEASE PROGRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PRECANCEROUS CONDITIONS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; WARTS;

EID: 0042123509     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses. Developed and approved at the National Cancer Institute Workshop, Bethesda, Maryland, U.S.A., December 12-13, 1988. Acta Cytol 33: 567-574, 1989.
2. Bonin SR, Pajak TF, Russell AH, Coia LR, Paris KJ, Flam MS and Sauter ER: Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group. Cancer 85: 1226-1233, 1999.
3. Brash DE and Ponten J: Skin precancer. Cancer Surv 32: 69-113, 1998.
4. Chang J, Powles TJ, Allred DC, Ashley SE, Clark GM, Makris A, Assersohn L, Gregory RK, Osborne CK and Dowsett M: Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer. J Clin Oncol 17: 3058-3063, 1999.
5. Chin-Hong PV and Palefsky JM: Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 35: 1127-1134, 2002.
6. Critchlow CW, Surawicz CM, Holmes KK, Kuypers J, Daling JR, Hawes SE, Goldbaum GM, Sayer J, Hurt C and Dunphy C: Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 9: 1255-1262, 1995.
7. Dorkin TJ, Robson CN and Neal DE: The molecular pathology of urological malignancies. J Pathol 183: 380-387, 1997.
8. Frisch M, Melbye M and Moller H: Trends in incidence of anal cancer in Denmark. BMJ 306: 419-422, 1993.
9. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, De Nictolis M, Fabris G and Biagini G: p53 immunostaining and HPV DNA detection by PCR in cervical intraepithelial neoplasia: clinical implications of a combinated evaluation. Anticancer Res 17: 555-560, 1997.
10. Gorgoulis V, Rassidakis G, Karameris A, Giatromanolaki A, Barbatis C and Kittas C: Expression of p53 protein in laryngeal squamous cell carcinoma and dysplasia: possible correlation with human papillomavirus infection and clinicopathological findings. Virchows Arch 425: 481-489, 1994.
11. Hardy RG, Meltzer SJ and Jankowski JA: ABC of colorectal cancer. Molecular basis for risk factors. BMJ 321: 886-889, 2000.
12. Herbsleb M, Knudsen UB, Orntoft TF, Bichel P, Norrild B, Knudsen A and Mogensen O: Telomerase activity, MIB-1, PCNA, HPV 16 and p53 as diagnostic markers for cervical intraepithelial neoplasia. APMIS 109: 607-617, 2001.
13. Kramer A, Neben K and Ho AD: Centrosome replication, genomic instability and cancer. Leukemia 16: 767-775, 2002.
14. Lacey HB, Wilson GE, Tilston P, Wilkins EG, Bailey AS, Corbitt G and Green PM: A study of anal intraepithelial neoplasia in HIV positive homosexual men. Sex Transm Infect 75: 172-177, 1999.
15. Lai MD, Luo MJ, Yao JE and Chen PH: Anal cancer in Chinese: human papillomavirus infection and altered expression of p53. World J Gastroenterol 4: 298-302, 1998.
16. MacCallum DE and Hall PA: The biochemical characterization of the DNA binding activity of pKi67. J Pathol 191: 286-298, 2000.
17. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T and Palefsky J: Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 285: 2995-3002, 2001.
18. Nakopoulou L, Constantinides C, Papandropoulos J, Theodoropoulos G, Tzonou A, Giannopoulos A, Zervas A and Dimopoulos C: Evaluation of overexpression of p53 tumor suppressor protein in superficial and invasive transitional cell bladder cancer: comparison with DNA ploidy. Urology 46: 334-340, 1995.
19. Ogunbiyi OA, Scholefield JH, Raftery AT, Smith JH, Duffy S, Sharp F and Rogers K: Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 81: 365-367, 1994.
20. Ogunbiyi OA, Scholefield JH, Smith JH, Polacarz SV, Rogers K and Sharp F: Immunohistochemical analysis of p53 expression in anal squamous neoplasia. J Clin Pathol 46: 507-512, 1993.
21. Padovan P, Salmaso R, Marchetti M and Padovan R: Prognostic value of bcl-2, p53 and Ki-67 in invasive squamous carcinoma of the uterine cervix. Eur J Gynaecol Oncol 21: 267-272, 2000.
22. Palefsky JM: Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol 27: 471-479, 2000.
23. Palefsky JM, Holly EA, Ralston ML, Da Costa M and Greenblatt RM: Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 183: 383-391, 2001.
24. Pontén J and Guo Z: Precancer of the human cervix. Cancer Surv 32: 201-229, 1998.
25. Scholefield JH, Ogunbiyi OA, Smith JH, Rogers K and Sharp F: Treatment of anal intraepithelial neoplasia. Br J Surg 81: 1238-1240, 1994.
26. Scholefield JH, Sonnex C, Talbot IC, Palmer JG, Whatrup C, Mindel A and Northover JM: Anal and cervical intraepithelial neoplasia: possible parallel. Lancet 2: 765-769, 1989.
27. Smith HS, Lu Y, Deng G, Martinez O, Krams S, Ljung BM, Thor A and Lagios M: Molecular aspects of early stages of breast cancer progression. J Cell Biochem Suppl 17G: 144-152, 1993.
28. Syrjänen SM and Syrjänen KJ: New concepts on the role of human papillomavirus in cell cycle regulation. Ann Med 31: 175-187, 1999.
29. Werner M, Mueller J, Walch A and Hofler H: The molecular pathology of Barrett's esophagus. Histol Histopathol 14: 553-559, 1999.
30. Zwerschke W and Jansen-Durr P: Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv Cancer Res 78: 1-29, 2000.